Herbert Irving Comprehensive Cancer Center

Herbert Irving Comprehensive Cancer Center (HICCC) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, founded in 1911 at Columbia University Medical Center and part of the New York–Presbyterian Hospital Complex. The HICCC has more than 250 faculty members, 12 core facilities, and eight research programs within three divisions.[1]

Research

There are eight research programs at HICCC divided into three divisions. The basic science division includes programs in cancer regulatory networks and cancer genetics and epigenetics. Programs in the disease-specific division focus on breast cancer, hematological cancer, prostate cancer, and neuro-oncology. The population science division includes cancer epidemiology and prevention, control, and disparities.

The center is currently receiving over $33 million in funding from the NIH.[2]

Patient Care

Patients are treated at NewYork-Presbyterian Hospital. HICCC physicians treat more than 3,500 patients annually. There are over 200 clinical trials available to patients.[3]

History

HICCC first opened in 1911 as the Institute for Cancer Research and received its NCI designation in 1972, being promoted to comprehensive status in 1979. HICCC was previously led by Stephen G. Emerson, and the current interim director is Cory Abate-Shen, with Gary Schwartz as the deputy directory.[4]

Notable faculty

References
  1. "Herbert Irving Comprehensive Cancer Center awarded $18 million grant | EurekAlert! Science News". Eurekalert.org. 2014-08-27. Retrieved 2017-05-22.
  2. "About the Herbert Irving Comprehensive Cancer Center | Herbert Irving Comprehensive Cancer Center". Hiccc.columbia.edu. Retrieved 2017-05-22.
  3. "Diseases and Treatments | Herbert Irving Comprehensive Cancer Center". Hiccc.columbia.edu. Retrieved 2017-05-22.
  4. "About the Herbert Irving Comprehensive Cancer Center | Herbert Irving Comprehensive Cancer Center". Columbia.edu. Retrieved 2017-05-22.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.